Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- Check4 days agoChange DetectedThe page now states that recruitment has ended ('No longer looking for participants') and adds sections to help readers understand and join a study (How to Read a Study Record, Common Questions, How to Join a Study). The header formatting for Intervention/Treatment is standardized and a new revision stamp (v3.6.0) appears, replacing the previous v3.5.5.SummaryDifference0.4%

- Check11 days agoChange DetectedRevision: v3.5.5 has been added, replacing v3.5.4. This reflects a minor internal update to the page’s metadata or layout without altering the study data.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe record now shows revision v3.5.4, replacing v3.5.3, indicating a minor metadata update to the page without changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s displayed interface revision was updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than an update to the study details.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.0 to v3.5.2 (adding v3.5.2 and removing v3.5.0).SummaryDifference0.0%

- Check82 days agoChange DetectedAdded the term 'Severe myoclonic epilepsy in infancy' as a keyword/MeSH term and removed 'Dravet syndrome'.SummaryDifference0.0%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.